Tazemetostat hydrobromide

Tazemetostat hydrobromide (EPZ-6438 hydrobromide) is a potent, selective, and orally available inhibitor of EZH2. It inhibits EZH2 with IC50 values of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat hydrobromide also inhibits EZH1 with an IC50 of 392 nM.

Trivial name EPZ-6438 hydrobromide
Catalog Number E4850
Molecular Formula C21H20N2O5
CAS# 1467052-75-0
Inchi InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)
Inchi Key BHLXTPHDSZUFHR-UHFFFAOYSA-N
SMILES CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N
Size 1g
Supplier Page http://www.selleckchem.com/products/tazemetostat-hydrobromide.html
Additional Information https://file.selleck.cn/downloads/struct/E4850-Tazemetostat-hydrobromide-chemical-structure.png